BIOMAT Database Logo BIOMAT Database Logo

Synthesis of new pyrazolo[3,4-d]pyrimidine derivatives and evaluation of their anti-inflammatory and anticancer activities. 2017

Heba A Abd El Razik, and Mohamad Mroueh, and Wissam H Faour, and Wassim N Shebaby, and Costantine F Daher, and Hayam M A Ashour, and Hanan M Ragab
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.

This study reports the synthesis of two series of new purine bioisosteres comprising a pyrazolo[3,4-d]pyrimidine scaffold linked to piperazine moiety through different amide linkages. The newly synthesized compounds were evaluated for anticancer activity against four cell lines (MDA-MB-231, MCF-7, SF-268, B16F-10) and cyclooxygenase (COX-2) protein expression inhibition in lipopolysaccharide (LPS)-activated rat monocytes. The results revealed that most of the synthesized compounds showed moderate-to-high cytotoxic activity against at least one cell line, with compound 10b being the most active against all used cell lines (IC50 values 5.5-11 μg/ml) comparable to cisplatin. In addition, six of these compounds (7b, 10a-d, and 12c) demonstrated inhibition of LPS-induced COX-2 protein expression at low concentration (25 μg/ml) as compared to the control non-stimulated cells and showed a COX-2 selectivity index range comparable to diclofenac sodium. The overall results indicate that many of these pyrazolopyrimidine derivatives possess in vitro anti-inflammatory and anticancer activities at varying doses, and the most active compounds will be subjected to in vivo pharmacological evaluation.

UI MeSH Term Description Entries
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004008 Diclofenac A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt. Diclophenac,Dichlofenal,Diclofenac Potassium,Diclofenac Sodium,Diclonate P,Dicrofenac,Feloran,GP-45,840,Novapirina,Orthofen,Orthophen,Ortofen,SR-38,Sodium Diclofenac,Voltaren,Voltarol,Diclofenac, Sodium,GP 45,840,GP45,840,SR 38,SR38
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

Heba A Abd El Razik, and Mohamad Mroueh, and Wissam H Faour, and Wassim N Shebaby, and Costantine F Daher, and Hayam M A Ashour, and Hanan M Ragab
Some pyrazole and pyrazolo[3,4-d]pyrimidine derivatives: synthesis and anticancer evaluation.
August 2014, Archiv der Pharmazie,
Heba A Abd El Razik, and Mohamad Mroueh, and Wissam H Faour, and Wassim N Shebaby, and Costantine F Daher, and Hayam M A Ashour, and Hanan M Ragab
Design, synthesis and anticancer evaluation of novel pyrazole, pyrazolo[3,4-d]pyrimidine and their glycoside derivatives.
April 2017, Nucleosides, nucleotides & nucleic acids,
Heba A Abd El Razik, and Mohamad Mroueh, and Wissam H Faour, and Wassim N Shebaby, and Costantine F Daher, and Hayam M A Ashour, and Hanan M Ragab
Synthesis of some new pyrazolo[3,4-d]pyrimidine derivatives of expected anticancer and radioprotective activity.
January 2010, European journal of medicinal chemistry,
Heba A Abd El Razik, and Mohamad Mroueh, and Wissam H Faour, and Wassim N Shebaby, and Costantine F Daher, and Hayam M A Ashour, and Hanan M Ragab
[Synthesis of new derivatives of pyrazole and pyrazolo[3,4-d]pyrimidine].
January 1985, Acta poloniae pharmaceutica,
Heba A Abd El Razik, and Mohamad Mroueh, and Wissam H Faour, and Wassim N Shebaby, and Costantine F Daher, and Hayam M A Ashour, and Hanan M Ragab
Design, synthesis and evaluation of some pyrazolo[3,4-d]pyrimidine derivatives bearing thiazolidinone moiety as anti-inflammatory agents.
October 2018, Bioorganic chemistry,
Heba A Abd El Razik, and Mohamad Mroueh, and Wissam H Faour, and Wassim N Shebaby, and Costantine F Daher, and Hayam M A Ashour, and Hanan M Ragab
Novel pyrazolo[3,4-d]pyrimidine derivatives: design, synthesis, anticancer evaluation, VEGFR-2 inhibition, and antiangiogenic activity.
December 2023, RSC medicinal chemistry,
Heba A Abd El Razik, and Mohamad Mroueh, and Wissam H Faour, and Wassim N Shebaby, and Costantine F Daher, and Hayam M A Ashour, and Hanan M Ragab
Design, Synthesis, and Antitumor Evaluation of Novel Pyrazolo[3,4-d]pyrimidine Derivatives.
January 2012, Scientia pharmaceutica,
Heba A Abd El Razik, and Mohamad Mroueh, and Wissam H Faour, and Wassim N Shebaby, and Costantine F Daher, and Hayam M A Ashour, and Hanan M Ragab
Anti-inflammatory drug approach: Synthesis and biological evaluation of novel pyrazolo[3,4-d]pyrimidine compounds.
May 2019, Bioorganic chemistry,
Heba A Abd El Razik, and Mohamad Mroueh, and Wissam H Faour, and Wassim N Shebaby, and Costantine F Daher, and Hayam M A Ashour, and Hanan M Ragab
Synthesis and antitumor properties of pyrazolo [3,4-D] pyrimidine derivatives.
January 1987, Polish journal of pharmacology and pharmacy,
Heba A Abd El Razik, and Mohamad Mroueh, and Wissam H Faour, and Wassim N Shebaby, and Costantine F Daher, and Hayam M A Ashour, and Hanan M Ragab
Anticancer and Anti-Inflammatory Activities of Some New Pyrazolo[3,4-b]pyrazines.
October 2018, Molecules (Basel, Switzerland),
Copied contents to your clipboard!